What Makes Our Stem Cell Treatment for Stroke Effective?
Since 2005, we have been developing extensive protocols regarding stem cell treatment for stroke to overcome the limitations of conventional therapies. In our protocols, stem cells are combined with specialized therapies for stroke that not only focus on helping the patient to cope with their symptoms, but also treat the root cause of the symptoms by promoting the healing of the original brain lesion. We believe that our comprehensive stem cell treatment for stroke gives our patients the best chances of improvements, allowing for a better quality of life.
What potential improvements after the treatment?
The purpose of the treatment is to heal the original brain injury in order to restore neurological function. Thus, various kinds of improvement are possible after our treatment and our past patients have experienced the following*:
- Improved motor functions
- Increased muscle strength
- Improved speech
- Decreased spasticity
- Improved vision
- Improved social skills and communication
*It is important to remember that as for any medical treatment, improvements cannot be guaranteed. Please contact us for more information regarding the possible improvements for a particular case.
Debbie’s Stem Cell Journey
Dissatisfied with conventional stroke treatment, Debbie Zagone and her husband sought out Beike Biotechnology’s adult stem cell treatment protocols.
Find out more about patients previously treated with Beike stem cell protocols. The families participating in these blog posts talk about their stories and present their own view of the treatment, including thoughts regarding the daily therapies, the stem cell injection themselves as well as improvement noticed during and after treatment.
Stem Cell Therapy For Stroke News Stroke Stroke Patient In 2015 and in her early 30’s, Renata had a left cerebellar ischemic stroke in the pons of the brainstem. The stroke, caused by thrombosis (a blood clot) in the basilar artery, resulted in tetraparesis, or partial loss of function in … read more
In late 2014 a Stroke Patient Debbie Zagone suffered an ischemic stroke. Not satisfied with the conventional treatment she and her husband decided to seek out alternative treatments and discovered Beike Biotechnology. Beike comprehensive stem cell therapy has been used to treat over 22,500 patients with various chronic conditions. Stroke patient … read more
⏲️ 3 mins read Saif, a 15-year-old boy from the United States is back for his 6th treatment with Beike Biotech. His mom, kindly accepted to respond to a Q&A session about our stem cell treatment. We chose Beike after detailed research and it was one of the best decisions we’ve made. Tell … read more
Our Treatment Program in Details
Beike is unlike any other stem cell treatment provider in the world, the reason? Since 2005, we have been developing and optimizing our stem cell treatment protocols with the concept that only a very comprehensive solution can allow our patients to truly benefit from stem cells. We believe that stimulation through various therapies is necessary to enhance stem cell regenerative response, therefore our protocols include daily therapies to support the stem cells. Finally, we provide a wide variety and large quantities of stem cells in order to adapt to each patient specific condition and deliver maximized regenerative potential.
Our stem cell treatment for stroke program consist in 6 to 8 simple and minimally invasive injections of umbilical cord derived stem cells. The stem cells are transplanted using two separate methods: by intravenous way using a standard IV drip system, and through intrathecal injection performed after lumbar puncture. These two delivery methods allow for increased efficacy while ensuring safety and minimum inconvenience for the patient.
- 15 to 23 Days Stay
- IV & Intrathecal Injections
- UCBSC / UCMSC Cells
- Daily Therapy Program
- 120-400 Million Cells
- Nutrition Program
Stem Cell Quality and Quantity Ensured
Different types of stem cells for different needs
Beike provides stem cells from two separate sources: umbilical cord blood and umbilical cord tissue. Umbilical cord related samples are donated by healthy mothers after normal births and are sent to Beike Biotech’s laboratories for processing.
After reviewing the patient’s full medical information, our doctors will recommend which source of stem cells should be used for treatment. Our treatment protocols may include one or multiple types of stem cells in combination depending on each patient’s specific condition.
Highest International Stem Cell Processing Standards
Beike Biotechnology is processing its own adult stem cells in its internationally accredited laboratories. The company has full control over the processing and quality control of all stem cell products, ensuring perfect safety and highest quality. Processing methods and facility are accredited by the American Association of Blood Banks (AABB), the highest international standard in the industry.
Below are video interviews recorded during treatment with Beike stem cells. The families showcased in these videos talk about their personal stories and their experience of the treatment including the improvement noticed. The improvements mentioned in these videos are typical, however it does not guarantee that all patients may have the same improvements.
Why Choose Beike?
Experience: With more than a decade of practice, you are ensured to be advised and treated by competent professionals.
Safety: Accredited by the American Association of Blood Banks (AABB) and following highest international standards, our stem cell processing methods and laboratories ensure that you receive the best stem cell quality available.
Diversity: Multiple types of stem cells having different capabilities are available to adapt to each patient’s specific condition. We do not use the same type of stem cells for all patients.
Extensiveness: A complete supportive therapy program is provided daily to stimulate patient’s freshly transplanted stem cells. The best improvement can only be obtain by supporting your stem cells.
Support: A full follow-up program is provided after the treatment and you will be asked to take part in it at 1, 3, 6 and 12 months after treatment. Access to our team after the treatment is very important as you may receive further advice to maximize improvements.
Learn More About Us
Founded in July 2005, Shenzhen Beike Biotechnology is a national high-tech enterprise specialized in clinical transformation and technical service of biological treatment technology of strategic emerging industries.